Commonly prescribed thyroid drug levothyroxine was linked with bone mass and bone density loss in a cohort of older adults in ...

The loss of bone mineral density and bone mass is called osteoporosis, a disease that affects an estimated 10 million ...

Levothyroxine, the second most commonly prescribed medication among older adults in the U.S., may be associated with bone ...

Prescribed to treat hypothyroidism and thyroid cancer, around 7% of the U.S. population takes levothyroxine. The drug is a ...

Recent research has highlighted the bone-health risks of taking thyroid medication, prescribed to 23 million Americans.

New research presented at the RSNA meeting suggests that levothyroxine, a common treatment for hypothyroidism, may contribute ...

A new study reveals a potential link between levothyroxine, a common treatment for underactive thyroid, and bone loss in ...

Levothyroxine (LT4) use is associated with longitudinal loss of bone mass and density in older adults, according to a study ...

The researchers used the Baltimore Longitudinal Study of Aging, a prospective cohort study of community-dwelling older adults.

Levothyroxine, the second-most-commonly prescribed medication for older adults in the U.S., has been linked to lower bone density.

Levothyroxine — marketed under brand names such as Synthroid — is the second-most commonly prescribed medication among older adults in the US. It’s consumed by about 7% of the US population.